| abstract |
The invention provides a pharmaceutical composition for treating benign prostatic hyperplasia, which is prepared from the following raw materials by weight: 10.5-19.5 parts of cinnamon, 7-13 parts of aconite, 10.5-19.5 parts of Achyranthes, Rehmannia glutinosa 10.5-19.5 parts, dogwood 21-39 parts, yam 21-39 parts, Poria 21-39 parts, Alisma 21-39 parts, psyllium 21-39 parts, amber 3.5-6.5 parts, peony bark 21- 39 copies, 7 to 13 copies of soil soft-shelled turtle. The pharmaceutical composition provided by the invention has a precise formula, can significantly relieve the clinical symptoms of patients with benign prostatic hyperplasia, effectively treat the benign prostatic hyperplasia, and the composition of the invention has good safety, no toxic and side effects, and is convenient to use, and provides a clinical new drug options. |